All lobbying filings

Continental Strategy, LLC

Continental Strategy, LLC filed a Q4 report for Dexcom on January 19, 2026, reporting $75,000 in lobbying income.

Lobbying for Dexcom · Healthcare company that develops, manufactures, produces, and distributes CGMs.

As filed: CONTINENTAL STRATEGY, LLC for DEXCOM.

All filings by Continental Strategy, LLC · Everything Dexcom has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$75,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 1

Executive Office of the President (EOP)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

continuous glucose monitoring

Medical/Disease Research/Clinical Labs

continuous glucose monitoring

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.